Request Appointment
12902 Usf Magnolia DrTampa, FL 33612
Fax+1 813-979-3027
Overview of Dr. Chiappori
Dr. Alberto Chiappori is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Cayetano Heredia University and has been in practice 37 years. Dr. Chiappori accepts several types of health insurance, listed below. He is one of 200 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1997
Southern Illinois UniversityResidency, Internal Medicine, 1990 - 1993
Cayetano Heredia UniversityClass of 1989
Certifications & Licensure
FL State Medical License 2001 - 2027
KY State Medical License 1997 - 2002
IL State Medical License 1990 - 1999
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2014, 2016
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016
- CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2014, 2016
Clinical Trials
- Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer Start of enrollment: 2003 Jul 01
- Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Start of enrollment: 2006 Nov 01
- Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer Start of enrollment: 2006 Oct 01
Publications & Presentations
PubMed
- Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use.Utsav Joshi, Faustine Ong, Daniel Melzer, Joanna C Ma, Andreas Saltos
Clinical Lung Cancer. 2026-03-01 - A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancer.Hirva Mamdani, Ryan D Gentzler, Lin Gu, Alberto A Chiappori, Frank D Weinberg
Cancer. 2025-11-01 - 2 citationsNOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING.Yoo Sun Kim, Barzin Y Nabet, Briana N Cortez, Nai-Yun Sun, Robin Sebastian
The Journal of Clinical Investigation. 2025-09-16
Journal Articles
- Overall Survival with Durvalumab After Chemoradiotherapy in Stage III NSCLCDavid R Spigel, Davey Daniel, Jhanelle E Gray, Augusto Villegas, Tarek Mekhail, Alberto Chiappori, The New England Journal of Medicine
Press Mentions
Mesothelioma Find Out About Explores New Remedy When Chemotherapy FailsAugust 27th, 2021
Mesothelioma Study Explores New Treatment When Chemotherapy FailsAugust 26th, 2019
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open AccessCIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
